We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Urine Test Validated for Schistosomiasis

By LabMedica International staff writers
Posted on 16 Jan 2012
Urogenital schistosomiasis in chronically infected adults can be diagnosed by the detection of parasite specific DNA fragments.

The sensitivity and specificity of three tests have been evaluated for the viable infection of Schistosoma haematobium in the urogenital tract, which included a polymerase chain reaction hematuria, and the presence of parasite eggs.

A team of collaborating scientists under the auspices of those at Johns Hopkins University (Baltimore, MD, USA) collected over 400 urine samples from adult volunteers in an endemic area in Western Nigeria. These were assessed for hematuria then filtered in the field, the filter papers dried and later examined for eggs and DNA. The results were stratified according to sex and age and subjected to Latent Class analysis.

The DNA was precipitated and concentrated using the Qiagen QIAmp (Qiagen; Germantown, MD, USA) mini- kit. The extracted DNA was used for PCR amplification. The primers were designed to amplify the 121 bp tandem repeat restriction endonuclease from Deinococcus radiophilus (Dra-1) sequence of S. haematobium. Each urine sample was tested with a Hemastix (Bayer; Elkhart, IN, USA) test strip to detect hematuria.

The PCR test indicating the presence of Dra1 DNA fragments in males was 100% for both sensitivity and specificity. This exceeded hematuria with a sensitivity and specificity of 87.6% and 34.7%, respectively, while the detection of eggs, the sensitivity was 70.1% and specificity was 100%. There were similar results for the females except the specificity of the hematuria was 77.0%.

To test the effect of parasite clearance on the persistence of Dra1 fragment, a group of 55 persons who were positive either for presence of parasites eggs and/or DNA in the urine, were followed up two weeks after treatment with praziquantel. Of these 26 (47.3%) were positive for parasite eggs and 42 (76.4%) were positive for DNA. None of these people were positive for eggs or parasite specific DNA in the follow up.

The authors concluded that the molecular test is extremely promising for the diagnosis of urogenital schistosomiasis and should also be useful in field studies as it will be able to reveal infections in people frequently presumed to be uninfected. The PCR test indicated the presence of schistosomes in 10.7% of adults who did not pass eggs in urine specimens. The study was published online on January 3, 2012, in the journal Public Library of Science Neglected tropical Diseases (PLoSNTD).

Related Links:

Johns Hopkins University
Qiagen
Bayer



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Respiratory QC Panel
Assayed Respiratory Control Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.